SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001651308-24-000032
Filing Date
2024-03-20
Accepted
2024-03-20 16:10:08
Documents
14
Period of Report
2024-03-19
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K bgne-20240319.htm   iXBRL 8-K 39783
2 EX-10.1 a202403ormxpaoanddirectorc.htm EX-10.1 24559
  Complete submission text file 0001651308-24-000032.txt   195766

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT bgne-20240319.xsd EX-101.SCH 1901
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT bgne-20240319_lab.xml EX-101.LAB 22448
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT bgne-20240319_pre.xml EX-101.PRE 13019
17 EXTRACTED XBRL INSTANCE DOCUMENT bgne-20240319_htm.xml XML 2866
Mailing Address C/O MOURANT GOVERNANCE SERVICES (CAYMAN) 94 SOLARIS AVENUE, CAMANA BAY GRAND CAYMAN E9 KY1-1108
Business Address C/O MOURANT GOVERNANCE SERVICES (CAYMAN) 94 SOLARIS AVENUE, CAMANA BAY GRAND CAYMAN E9 KY1-1108 13459494123
BeiGene, Ltd. (Filer) CIK: 0001651308 (see all company filings)

IRS No.: 981209416 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37686 | Film No.: 24767871
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)